These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8399677

  • 1. Establishing an experimental infection model for peritoneal dialysis: effect of inoculum and volume.
    Calame W, Afram C, Blijleven N, Hendrickx RJ, Namavar F, Beelen RH.
    Perit Dial Int; 1993; 13 Suppl 2():S79-80. PubMed ID: 8399677
    [Abstract] [Full Text] [Related]

  • 2. Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis.
    McGuire AL, Mulroney KT, Carson CF, Ram R, Morahan G, Chakera A.
    PLoS One; 2017; 12(5):e0178151. PubMed ID: 28542390
    [Abstract] [Full Text] [Related]

  • 3. Effect of glucose concentration and dwell time of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats.
    Calame W, Hendrickx RJ, Oe LP, Namavar F, Beelen RH.
    Adv Perit Dial; 1992; 8():219-22. PubMed ID: 1361790
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of caspases improves bacterial clearance in experimental peritonitis.
    Catalan MP, Esteban J, Subirá D, Egido J, Ortiz A, Grupo de Estudios Peritoneales de Madrid-FRIAT/IRSIN.
    Perit Dial Int; 2003; 23(2):123-6. PubMed ID: 12713077
    [Abstract] [Full Text] [Related]

  • 5. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF, Faller B, Mengus C, Wagner JD, Frey G.
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [Abstract] [Full Text] [Related]

  • 6. Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity.
    Calame W, Hendrickx RJ, Namavar F, Oe LP, Beelen RH.
    J Infect; 1995 May; 30(3):227-33. PubMed ID: 7673747
    [Abstract] [Full Text] [Related]

  • 7. Can we reduce rates of Staphylococcus aureus and other peritonitis in peritoneal dialysis patients?
    Piraino B.
    Perit Dial Int; 2010 May; 30(3):277-9. PubMed ID: 20424197
    [No Abstract] [Full Text] [Related]

  • 8. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis.
    Buggy BP, Schaberg DR, Swartz RD.
    Am J Med; 1984 Jun; 76(6):1035-40. PubMed ID: 6731461
    [Abstract] [Full Text] [Related]

  • 9. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M, Hauer S, Pichler P, Reznicek G, Burgmann H, Poeppl W, Zeitlinger M, Wiesholzer M.
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [Abstract] [Full Text] [Related]

  • 10. Biomaterial-associated staphylococcal peritoneal infections in a neutropaenic mouse model.
    Rozalska B, Ljungh A.
    FEMS Immunol Med Microbiol; 1995 Jul; 11(4):307-19. PubMed ID: 8541809
    [Abstract] [Full Text] [Related]

  • 11. Exit-site infection and acute peritonitis due to peritoneal dialysis catheter rupture.
    Knehtl M, Ekart R, Bevc S, Horvat M, Hojs R.
    Perit Dial Int; 2015 Jul; 35(3):362-3. PubMed ID: 26015420
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
    Cavanagh JP, Granslo HN, Fredheim EA, Christophersen L, Jensen PØ, Thomsen K, Van Gennip M, Klingenberg C, Flaegstad T, Moser C.
    J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
    [Abstract] [Full Text] [Related]

  • 13. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients.
    Piraino B.
    Am J Kidney Dis; 1990 Aug; 16(2):89-95. PubMed ID: 2200261
    [Abstract] [Full Text] [Related]

  • 14. Development of an in-vitro model to study the growth characteristics of Staphylococcus epidermidis in continuous ambulatory peritoneal dialysis.
    Brant JA, Hanlon GW, Denyer SP.
    J Pharm Pharmacol; 1998 Oct; 50(10):1195-203. PubMed ID: 9821670
    [Abstract] [Full Text] [Related]

  • 15. Staphylococcal peritonitis in patients on continuous peritoneal dialysis.
    West TE, Walshe JJ, Krol CP, Amsterdam D.
    J Clin Microbiol; 1986 May; 23(5):809-12. PubMed ID: 3711267
    [Abstract] [Full Text] [Related]

  • 16. Time to Positivity of Bacteria Cultures in Peritoneal Dialysis Fluid: Evaluation of Different Laboratory Techniques.
    Katzap RM, Pagnussatti VE, Figueiredo AE, Motta JG, d'Avila DO, da Costa BEP, Poli-de-Figueiredo CE.
    Perit Dial Int; 2017 May; 37(3):342-344. PubMed ID: 28512164
    [Abstract] [Full Text] [Related]

  • 17. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF, Comty CM, Verbrugh HA, Peterson PK.
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [Abstract] [Full Text] [Related]

  • 18. Effect of interferon-gamma in dialysis fluid on peritoneal defence in rats.
    Calame W, Hendrickx RJ, Namavar F, Beelen RH.
    Nephrol Dial Transplant; 1995 Mar; 10(7):1212-7. PubMed ID: 7478126
    [Abstract] [Full Text] [Related]

  • 19. Effect of dialysis on the clearance of Staphylococcus epidermidis from the peritoneal cavity: an experimental evaluation.
    Rowe L, Miller TE.
    Clin Nephrol; 1993 Aug; 40(2):106-13. PubMed ID: 8222366
    [Abstract] [Full Text] [Related]

  • 20. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Piraino B, Perlmutter JA, Holley JL, Bernardini J.
    Perit Dial Int; 1993 Aug; 13 Suppl 2():S332-4. PubMed ID: 8399602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.